Trademark: 79307379
Status Date
Tuesday, April 26, 2022
Registration Number
6709002
Registration Date
Tuesday, April 26, 2022
Filing Date
Tuesday, December 8, 2020
Published for Opposition
Tuesday, February 8, 2022
5 Medical and veterinary preparations for the treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases in humans and animals; pharmaceutical substances and preparations for human use for the diagnosis and treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases; biopharmaceutical substances and preparations for human use for use in the diagnosis and treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases; reagents, diagnostic preparations and therapeutic preparations in the nature of biological, biochemical and chemical reagents and vaccines for medical purposes; biological preparations for medical purposes, for the diagnosis and treatment of immune response disorders, cardiovascular diseases, genetic conditions, cancer, ophthalmological conditions, hematologic diseases, neurological disorders, respiratory diseases, metabolic diseases and infectious diseases; medical preparations for use in gene therapy; diagnostic preparations for medical purposes; therapeutic and diagnostic preparations, namely, small molecules for medical use
1 Chemicals used in science; biological preparations for use in science; biochemicals for research use; cell lines and bio-production cell lines for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; molecular biology research tools, in the nature of biological and biochemical reagents; biological and chemical reagents for research use; chemical reagents for scientific and research purposes; proteins in raw material form for scientific and medical research; gene extracts for research purposes; chemicals and biochemicals for drug discovery, lead identification, diagnostics, profiling and research
44 Medical services; medical and pharmaceutical advisory and consultancy services; preparing pharmaceuticals, namely pharmaceutical compounding services for others; providing personalised medicine services and personalised medical diagnostic reporting services; providing personal medical information; provision of medical information; provision of information to enable human diagnosis of medical conditions; providing medical information to enable healthcare professionals to enable the monitoring of patients; providing medical information to healthcare professionals to enable the assessment of progress in disease and treatment; consultancy and advisory relating to all the aforesaid services
42 Medical, scientific and industrial research services in the field of cells, cell therapies, genome editing, genetic engineering and gene therapies and targeting therapies to individuals; pharmaceutical and biopharmaceutical research and development services; medical and pharmacological research services; examination and testing of genes for scientific research purposes; development, examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; development, examination and testing of medicaments products; development of test systems for pharmaceutical and biopharmaceutical products; development of databases in the medical, pharmaceutical and biopharmaceutical field; development of gene databases; research and development services in the creation of databases and collections of information on biologicals, genetic material, genetic information, chemicals and compounds for research purposes; providing biological and medical research information; providing scientific research information and data in relation to health and disease state; medical research into personalised medicine; medical research services in the field of personalised diagnostics, medical research services in the field of personal medical profiles; provision of scientific research information in the field of personalised medicine; pharmaceutical drug development services; consultancy and advisory relating to all the aforesaid services
Sep 26, 2022
Final Decision Transaction Processed By Ib
Sep 2, 2022
Final Disposition Notice Sent To Ib
Sep 2, 2022
Final Disposition Processed
Jul 26, 2022
Final Disposition Notice Created, To Be Sent To Ib
May 27, 2022
Change Of Name/Address Rec'd From Ib
Apr 26, 2022
Registered-Principal Register
Feb 8, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 8, 2022
Published For Opposition
Feb 6, 2022
Notification Processed By Ib
Jan 20, 2022
Teas Change Of Correspondence Received
Jan 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 19, 2022
Notification Of Possible Opposition Sent To Ib
Jan 19, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 19, 2022
Notification Of Notice Of Publication E-Mailed
Jan 3, 2022
Approved For Pub - Principal Register
Dec 23, 2021
Examiner's Amendment Entered
Dec 23, 2021
Notification Of Examiners Amendment E-Mailed
Dec 23, 2021
Examiners Amendment E-Mailed
Dec 23, 2021
Examiners Amendment -Written
Dec 22, 2021
Notification Of Final Refusal Emailed
Dec 22, 2021
Final Refusal E-Mailed
Dec 22, 2021
Final Refusal Written
Dec 14, 2021
Teas/Email Correspondence Entered
Dec 14, 2021
Correspondence Received In Law Office
Dec 14, 2021
Teas Response To Office Action Received
Jul 11, 2021
Refusal Processed By Ib
Jun 21, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jun 21, 2021
Refusal Processed By Mpu
Jun 12, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jun 11, 2021
Non-Final Action Written
Jun 7, 2021
Non-Final Action (Ib Refusal) Withdrawn For Review
May 29, 2021
Non-Final Action (Ib Refusal) Prepared For Review
May 28, 2021
Non-Final Action Written
May 28, 2021
Assigned To Examiner
Mar 30, 2021
Application Filing Receipt Mailed
Mar 26, 2021
New Application Office Supplied Data Entered In Tram
Mar 25, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
